QBE North America Introduces Life Sciences Insurance Offering
"Life sciences companies face a unique and fast-changing risk landscape," said
The Life Sciences product provides liability protection for a wide range of classifications, including clinical trials, dental and medical devices, personal care, specialty pharmaceuticals, animal health products, and more.
QBE offers primary and excess Life Sciences liability coverages such as:
- Products completed operations
- Clinical trial liability
- Errors and omissions (E&O)
- General liability
- Healthcare professional liability
"Our new Life Sciences product offers flexible and comprehensive coverage," said
The launch expands QBE's Healthcare Liability portfolio following the introduction of its Miscellaneous Medical Liability product in 2024. That offering includes coverages for professional liability, physical & sexual misconduct liability, general liability, employee benefits liability, E&O, tech & media liability and excess/umbrella.
More information about QBE's Life Sciences product is available at qbe.com/us/healthcare-liability.
About QBE North America
QBE North America is a global insurance leader helping customers solve unique risks, so they can stay focused on their future. Part of QBE Insurance Group Limited, QBE North America reported Gross Written Premiums in 2024 of
View original content to download multimedia:https://www.prnewswire.com/news-releases/qbe-north-america-introduces-life-sciences-insurance-offering-302500214.html
SOURCE QBE North America
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Best Infrared Saunas of 2026 [Expert Reviewed and Independently Verified]
- MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
- Beyond 600 AI Employees: Tec-Do 2.0 Builds an Agent Skill Lab for Enterprise Productivity
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share